Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ9	positive	TECR	ENSG00000099797	COQ9	1	COQ9	1	0.000290942902401059	WBGene00000198	WBGene00000198(1)		Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 14	GO:0005634;GO:0016020;GO:0016021;GO:0005783;GO:0016491;GO:0055114;GO:0005789;GO:0016627;GO:0006629;GO:0006631;GO:0006633;GO:0042761;GO:0005515;GO:0006665;GO:0035338;GO:0030176;GO:0030497;GO:0102758	oxidoreductase activity, acting on the CH-CH group of donors;lipid metabolic process;nucleus;membrane;integral component of membrane;endoplasmic reticulum;oxidoreductase activity;oxidation-reduction process;endoplasmic reticulum membrane;fatty acid metabolic process;fatty acid biosynthetic process;very long-chain fatty acid biosynthetic process;protein binding;sphingolipid metabolic process;long-chain fatty-acyl-CoA biosynthetic process;integral component of endoplasmic reticulum membrane;fatty acid elongation;very-long-chain enoyl-CoA reductase activity	3D-structure;Acetylation;Alternative splicing;Disease mutation;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Membrane;Mental retardation;NADP;Oxidoreductase;Phosphoprotein;Reference proteome;Sphingolipid metabolism;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-75105;R-HSA-75876;R-HSA-8978868	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
COQ9	positive	FAHD2A	ENSG00000115042	COQ9	1	COQ9	1	0.000570862583965215	WBGene00022798				GO:0046872;GO:0016787;GO:0003824	catalytic activity;metal ion binding;hydrolase activity	Calcium;Hydrolase;Magnesium;Metal-binding;Polymorphism;Reference proteome		
COQ9	positive	MORN1	ENSG00000116151	COQ9	1	COQ9	1	0.000570862583965215							Alternative splicing;Polymorphism;Reference proteome;Repeat		
COQ9	positive	MED18	ENSG00000130772	COQ9	1	COQ9	1	0.000570862583965215	WBGene00007018	WBGene00007018(1)			GO:0005634;GO:0003712;GO:0006357;GO:0016592;GO:0005515;GO:0006369;GO:0070847	transcription coregulator activity;regulation of transcription by RNA polymerase II;mediator complex;nucleus;protein binding;termination of RNA polymerase II transcription;core mediator complex	Activator;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	R-HSA-1266738;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206	Developmental Biology;Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha
COQ9	positive	ALDH16A1	ENSG00000161618	COQ9	1	COQ9	1	0.000570862583965215		WBGene00000107(0);WBGene00000108(0);WBGene00000109(0)			GO:0016020;GO:0055114;GO:0016491;GO:0016620	oxidation-reduction process;oxidoreductase activity;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;membrane	Alternative splicing;Polymorphism;Reference proteome		
COQ9	positive	ZNF446	ENSG00000083838	COQ9	1	COQ9	1	0.00108404830259523		WBGene00003033(0);WBGene00001824(0);WBGene00012385(0)			GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003700;GO:0005622;GO:0003677;GO:0005615;GO:0006357;GO:0000981;GO:0000790;GO:0005515	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;DNA binding;extracellular space;protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	MZF1	ENSG00000099326	COQ9	1	COQ9	1	0.00108404830259523	WBGene00021931		PADI1;BLMH		GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0042803;GO:0005515;GO:0000981;GO:0000978;GO:0001227;GO:0000122;GO:0001228;GO:0045944;GO:0044212	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;DNA binding;protein homodimerization activity;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding	3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ9	positive	KCTD15	ENSG00000153885	COQ9	1	COQ9	1	0.00108404830259523	WBGene00009796	WBGene00009315(0)			GO:0051260;GO:0005515;GO:0007275;GO:0042802	protein homooligomerization;protein binding;multicellular organism development;identical protein binding	Alternative splicing;Developmental protein;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260;R-HSA-8866904	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
COQ9	positive	PAFAH2	ENSG00000158006	COQ9	1	COQ9	1	0.00108404830259523	WBGene00003906;WBGene00003907	WBGene00003906(1);WBGene00003907(1)			GO:0005737;GO:0016020;GO:0005783;GO:0005789;GO:0016787;GO:0006629;GO:0016042;GO:0007596;GO:0005543;GO:0003847;GO:0043066	lipid catabolic process;1-alkyl-2-acetylglycerophosphocholine esterase activity;cytoplasm;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;lipid metabolic process;blood coagulation;phospholipid binding;negative regulation of apoptotic process	Cytoplasm;Endoplasmic reticulum;Hydrolase;Lipid degradation;Lipid metabolism;Lipoprotein;Membrane;Myristate;Reference proteome	R-HSA-109582;R-HSA-418346	Hemostasis;Platelet homeostasis
COQ9	positive	PSKH1	ENSG00000159792	COQ9	1	COQ9	1	0.00108404830259523	WBGene00019911				GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0006468;GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0016301;GO:0016740;GO:0016310;GO:0005654;GO:0005783;GO:0005789;GO:0005794;GO:0005886;GO:0005856;GO:0005515;GO:0005815;GO:0007368;GO:0007507	ATP binding;protein phosphorylation;protein kinase activity;nucleotide binding;protein serine/threonine kinase activity;nucleus;cytoplasm;nuclear speck;membrane;kinase activity;transferase activity;phosphorylation;nucleoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;cytoskeleton;plasma membrane;protein binding;microtubule organizing center;determination of left/right symmetry;heart development	ATP-binding;Cell membrane;Cytoplasm;Cytoskeleton;Endoplasmic reticulum;Golgi apparatus;Kinase;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ9	positive	AFMID	ENSG00000183077	COQ9	1	COQ9	1	0.00108404830259523	WBGene00012866;WBGene00017051	WBGene00017051(0)			GO:0005634;GO:0005737;GO:0016787;GO:0005829;GO:0019441;GO:0009435;GO:0006569;GO:0034354;GO:0009056;GO:0004061	hydrolase activity;tryptophan catabolic process to kynurenine;arylformamidase activity;nucleus;cytoplasm;cytosol;tryptophan catabolic process;'de novo' NAD biosynthetic process from tryptophan;catabolic process;NAD biosynthetic process	Alternative splicing;Cytoplasm;Hydrolase;Nucleus;Reference proteome;Tryptophan catabolism	R-HSA-1430728;R-HSA-71291;R-HSA-71240	Metabolism;Metabolism of amino acids and derivatives;Tryptophan catabolism
COQ9	positive	ZNF74	ENSG00000185252	COQ9	1	COQ9	1	0.00108404830259523	WBGene00044651				GO:0003676;GO:0003723;GO:0005634;GO:0046872;GO:0005654;GO:0006355;GO:0003677;GO:0015629;GO:0007275;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;RNA binding;nucleus;metal ion binding;nucleoplasm;DNA binding;actin cytoskeleton;multicellular organism development	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	ANTKMT	ENSG00000103254	COQ9	1	COQ9	1	0.00199269197782681	WBGene00012658	WBGene00012658(0)			GO:0016020;GO:0016021;GO:0016740;GO:0008168;GO:0032259;GO:0005739;GO:0016279;GO:0031966;GO:0018023;GO:0018022	protein-lysine N-methyltransferase activity;membrane;integral component of membrane;transferase activity;methyltransferase activity;methylation;mitochondrion;mitochondrial membrane;peptidyl-lysine trimethylation;peptidyl-lysine methylation	Membrane;Methyltransferase;Mitochondrion;Reference proteome;S-adenosyl-L-methionine;Transferase;Transmembrane;Transmembrane helix		
COQ9	positive	MEGF8	ENSG00000105429	COQ9	1	COQ9	1	0.00199269197782681				CARPENTER SYNDROME;CARPENTER SYNDROME;CARPENTER SYNDROME 2	GO:0005634;GO:0016020;GO:0016021;GO:0005509;GO:0005515;GO:0009887;GO:0009888;GO:0070062;GO:0035108;GO:0030509;GO:0045879;GO:0048842;GO:0010468;GO:0048704;GO:0097155;GO:0030326;GO:0042074;GO:0097094;GO:0003143;GO:0055113;GO:0060971;GO:0060972;GO:0061371;GO:0071907;GO:0007368;GO:0060976	protein binding;calcium ion binding;nucleus;membrane;integral component of membrane;animal organ morphogenesis;tissue development;extracellular exosome;limb morphogenesis;BMP signaling pathway;negative regulation of smoothened signaling pathway;positive regulation of axon extension involved in axon guidance;regulation of gene expression;embryonic skeletal system morphogenesis;fasciculation of sensory neuron axon;embryonic limb morphogenesis;cell migration involved in gastrulation;craniofacial suture morphogenesis;embryonic heart tube morphogenesis;epiboly involved in gastrulation with mouth forming second;embryonic heart tube left/right pattern formation;left/right pattern formation;determination of heart left/right asymmetry;determination of digestive tract left/right asymmetry;determination of left/right symmetry;coronary vasculature development	Alternative splicing;Calcium;Craniosynostosis;Disease mutation;Disulfide bond;EGF-like domain;Glycoprotein;Kelch repeat;Laminin EGF-like domain;Membrane;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
COQ9	positive	CRTC1	ENSG00000105662	COQ9	1	COQ9	1	0.00199269197782681	WBGene00021237	WBGene00021237(0)	PPARGC1A		GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005886;GO:0051289;GO:0005515;GO:0016604;GO:0048511;GO:0045944;GO:0016032;GO:0032793;GO:0008140;GO:0043153;GO:0007613;GO:0097009;GO:0099527;GO:1900006;GO:1900273;GO:1902631;GO:0014069;GO:0030425;GO:0043025;GO:0045202;GO:0098978	nucleus;cytoplasm;protein homotetramerization;cAMP response element binding protein binding;positive regulation of CREB transcription factor activity;nucleoplasm;cytosol;plasma membrane;protein binding;nuclear body;rhythmic process;positive regulation of transcription by RNA polymerase II;viral process;entrainment of circadian clock by photoperiod;memory;energy homeostasis;postsynapse to nucleus signaling pathway;positive regulation of dendrite development;positive regulation of long-term synaptic potentiation;negative regulation of membrane hyperpolarization;postsynaptic density;dendrite;neuronal cell body;synapse;glutamatergic synapse	Activator;Alternative splicing;Biological rhythms;Chromosomal rearrangement;Cytoplasm;Host-virus interaction;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-1852241;R-HSA-400253;R-HSA-1592230;R-HSA-2151201	Organelle biogenesis and maintenance;Circadian Clock;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis
COQ9	positive	ZNF576	ENSG00000124444	COQ9	1	COQ9	1	0.00199269197782681		WBGene00001824(0);WBGene00012385(0)			GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding	DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ9	positive	MRPL34	ENSG00000130312	COQ9	1	COQ9	1	0.00199269197782681					GO:0003735;GO:0006412;GO:0005840;GO:0005622;GO:0005739;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761	structural constituent of ribosome;translation;ribosome;mitochondrion;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome	3D-structure;Mitochondrion;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ9	positive	PGPEP1	ENSG00000130517	COQ9	1	COQ9	1	0.00199269197782681	WBGene00010858;WBGene00010856;WBGene00010857;WBGene00008897;WBGene00018056	WBGene00012252(0);WBGene00018056(0);WBGene00008897(0);WBGene00008894(0);WBGene00010858(1);WBGene00010856(0);WBGene00010857(0);WBGene00018057(0)			GO:0005737;GO:0016787;GO:0005829;GO:0008233;GO:0008234;GO:0006508;GO:0016920	proteolysis;pyroglutamyl-peptidase activity;cytosol;peptidase activity;cytoplasm;hydrolase activity;cysteine-type peptidase activity	Alternative splicing;Cytoplasm;Hydrolase;Protease;Reference proteome;Thiol protease		
COQ9	positive	RALGPS1	ENSG00000136828	COQ9	1	COQ9	1	0.00199269197782681					GO:0005737;GO:0016020;GO:0007264;GO:0005886;GO:0005085;GO:0005575;GO:0035556;GO:0008321;GO:0032485;GO:0005622	guanyl-nucleotide exchange factor activity;small GTPase mediated signal transduction;cytoplasm;membrane;plasma membrane;cellular_component;intracellular signal transduction;Ral guanyl-nucleotide exchange factor activity;regulation of Ral protein signal transduction	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Guanine-nucleotide releasing factor;Membrane;Polymorphism;Reference proteome		
COQ9	positive	SIRT3	ENSG00000142082	COQ9	1	COQ9	1	0.00199269197782681					GO:0008270;GO:0046872;GO:0016787;GO:0016575;GO:0005739;GO:0005759;GO:0070403;GO:0034979;GO:0006476;GO:0017136;GO:0005515;GO:0043565;GO:0005634;GO:0005737;GO:0005654;GO:0032991;GO:0007005;GO:0006471;GO:0003950;GO:0009060;GO:0034983;GO:2000304;GO:0019899;GO:0007568;GO:0032024;GO:0070373;GO:2000378	zinc ion binding;NAD+ binding;NAD-dependent histone deacetylase activity;metal ion binding;transferase activity;mitochondrion;mitochondrial matrix;NAD-dependent protein deacetylase activity;protein deacetylation;histone deacetylation;protein binding;sequence-specific DNA binding;nucleus;cytoplasm;nucleoplasm;protein-containing complex;mitochondrion organization;protein ADP-ribosylation;NAD+ ADP-ribosyltransferase activity;aerobic respiration;peptidyl-lysine deacetylation;positive regulation of ceramide biosynthetic process;enzyme binding;aging;positive regulation of insulin secretion;negative regulation of ERK1 and ERK2 cascade;positive regulation of superoxide dismutase activity;positive regulation of catalase activity;negative regulation of reactive oxygen species metabolic process	3D-structure;Alternative splicing;Metal-binding;Mitochondrion;NAD;Polymorphism;Reference proteome;Transferase;Transit peptide;Zinc	R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9614085;R-HSA-9615017;R-HSA-1592230;R-HSA-2151201;R-HSA-9617629	Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Regulation of FOXO transcriptional activity by acetylation
COQ9	positive	SFXN5	ENSG00000144040	COQ9	1	COQ9	1	0.00199269197782681	WBGene00044049;WBGene00011440	WBGene00044049(1)			GO:0016020;GO:0016021;GO:0055085;GO:0006811;GO:0034220;GO:0005739;GO:0015075;GO:0031966;GO:0006865;GO:0015137;GO:0015746	membrane;ion transport;transmembrane transport;ion transmembrane transporter activity;integral component of membrane;ion transmembrane transport;mitochondrion;mitochondrial membrane;amino acid transport;transmembrane transporter activity;integral component of mitochondrial inner membrane;mitochondrial transmembrane transport;citrate transmembrane transporter activity;citrate transport	Amino-acid transport;Membrane;Mitochondrion;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ9	positive	TIRAP	ENSG00000150455	COQ9	1	COQ9	1	0.00199269197782681				BACTEREMIA SUSCEPTIBILITY TO 1;INVASIVE PNEUMOCOCCAL DISEASE RECURRENT ISOLATED 1;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED	GO:0070374;GO:0005737;GO:0016020;GO:0007165;GO:0005886;GO:0005515;GO:0006954;GO:0002376;GO:0045087;GO:0042802;GO:0005829;GO:0042803;GO:0046982;GO:0002755;GO:0032496;GO:0032735;GO:0032757;GO:0032760;GO:0051092;GO:0046330;GO:0043123;GO:0090023;GO:0030674;GO:0007166;GO:0071221;GO:0032587;GO:0030139;GO:2000343;GO:0050830;GO:0030890;GO:0005080;GO:0070935;GO:0034145;GO:0005546;GO:0035662;GO:0035663;GO:0007250;GO:0030099;GO:0032648;GO:0032738;GO:0034137;GO:0034141;GO:0035665;GO:0045088;GO:0045410;GO:0071223;GO:0090073;GO:2000340	protein binding;signal transduction;positive regulation of ERK1 and ERK2 cascade;cytoplasm;membrane;plasma membrane;inflammatory response;Toll-like receptor 4 binding;Toll-like receptor 2 binding;identical protein binding;regulation of innate immune response;immune system process;innate immune response;cytosol;positive regulation of protein-containing complex assembly;MyD88-dependent toll-like receptor signaling pathway;response to lipopolysaccharide;positive regulation of interleukin-12 production;positive regulation of interleukin-8 production;positive regulation of tumor necrosis factor production;positive regulation of NF-kappaB transcription factor activity;positive regulation of JNK cascade;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of neutrophil chemotaxis;protein binding, bridging;cell surface receptor signaling pathway;cellular response to bacterial lipopeptide;ruffle membrane;endocytic vesicle;positive regulation of chemokine (C-X-C motif) ligand 2 production;defense response to Gram-positive bacterium;positive regulation of B cell proliferation;protein kinase C binding;3'-UTR-mediated mRNA stabilization;positive regulation of toll-like receptor 4 signaling pathway;phosphatidylinositol-4,5-bisphosphate binding;activation of NF-kappaB-inducing kinase activity;myeloid cell differentiation;regulation of interferon-beta production;positive regulation of interleukin-15 production;positive regulation of toll-like receptor 2 signaling pathway;positive regulation of toll-like receptor 3 signaling pathway;TIRAP-dependent toll-like receptor 4 signaling pathway;positive regulation of interleukin-6 biosynthetic process;cellular response to lipoteichoic acid;positive regulation of chemokine (C-X-C motif) ligand 1 production	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Disulfide bond;Immunity;Inflammatory response;Innate immunity;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-983169;R-HSA-1643685;R-HSA-1236974;R-HSA-1236975;R-HSA-166016;R-HSA-166058;R-HSA-168179;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-5260271;R-HSA-5602358;R-HSA-5602498;R-HSA-5603041	Adaptive Immune System;Innate Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Disease;ER-Phagosome pathway;Antigen processing-Cross presentation;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4)
COQ9	positive	FLYWCH2	ENSG00000162076	COQ9	1	COQ9	1	0.00199269197782681					GO:0003723;GO:0008150;GO:0005575	RNA binding;biological_process;cellular_component	Phosphoprotein;Reference proteome		
COQ9	positive	ACOT11	ENSG00000162390	COQ9	1	COQ9	1	0.00199269197782681					GO:0005737;GO:0005829;GO:0016787;GO:0005739;GO:0005759;GO:0006629;GO:0006631;GO:0008289;GO:0016790;GO:0052689;GO:0070062;GO:0000062;GO:0016290;GO:0036042;GO:0047617;GO:0102991;GO:0006637;GO:0120163;GO:0035556;GO:0009266;GO:0009409	lipid binding;thiolester hydrolase activity;cytoplasm;cytosol;hydrolase activity;mitochondrion;mitochondrial matrix;lipid metabolic process;fatty acid metabolic process;carboxylic ester hydrolase activity;extracellular exosome;fatty-acyl-CoA binding;palmitoyl-CoA hydrolase activity;long-chain fatty acyl-CoA binding;acyl-CoA hydrolase activity;myristoyl-CoA hydrolase activity;acyl-CoA metabolic process;negative regulation of cold-induced thermogenesis;intracellular signal transduction;response to temperature stimulus;response to cold	3D-structure;Alternative splicing;Cytoplasm;Fatty acid metabolism;Hydrolase;Lipid metabolism;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine esterase;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation
COQ9	positive	NMNAT1	ENSG00000173614	COQ9	1	COQ9	1	0.00199269197782681	WBGene00009176;WBGene00012295			Cone rod dystrophy;Leber congenital amaurosis;Leber congenital amaurosis;LEBER CONGENITAL AMAUROSIS 9	GO:0005654;GO:0003824;GO:0009058;GO:0016604;GO:0005634;GO:0000166;GO:0005524;GO:0016740;GO:0005515;GO:0016779;GO:0000309;GO:0004515;GO:0009435;GO:0009611;GO:0019363;GO:0043410;GO:0043524;GO:1902511;GO:0005737;GO:0042802;GO:0009165;GO:0019674;GO:1990966	catalytic activity;biosynthetic process;nucleoplasm;nuclear body;NAD biosynthetic process;nucleotidyltransferase activity;nucleus;nucleotide binding;ATP binding;transferase activity;protein binding;nicotinamide-nucleotide adenylyltransferase activity;nicotinate-nucleotide adenylyltransferase activity;response to wounding;pyridine nucleotide biosynthetic process;positive regulation of MAPK cascade;negative regulation of neuron apoptotic process;negative regulation of neuron death;negative regulation of apoptotic DNA fragmentation;cytoplasm;identical protein binding;nucleotide biosynthetic process;NAD metabolic process;ATP generation from poly-ADP-D-ribose	3D-structure;ATP-binding;Direct protein sequencing;Disease mutation;Leber congenital amaurosis;Magnesium;NAD;Nucleotide-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Pyridine nucleotide biosynthesis;Reference proteome;Transferase;Zinc	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196807	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Nicotinate metabolism
COQ9	positive	TMEM80	ENSG00000177042	COQ9	1	COQ9	1	0.00199269197782681	WBGene00194710;WBGene00016247	WBGene00194710(0)			GO:0016020;GO:0016021;GO:0042995;GO:0005929;GO:0035869;GO:1905515	membrane;integral component of membrane;cell projection;cilium;ciliary transition zone;non-motile cilium assembly	Alternative initiation;Alternative splicing;Cell projection;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ9	positive	THAP7	ENSG00000184436	COQ9	1	COQ9	1	0.00199269197782681					GO:0003676;GO:0005634;GO:0016607;GO:0043231;GO:0046872;GO:0003677;GO:0031965;GO:0005694;GO:0005515;GO:0042802;GO:0006357;GO:0000981;GO:0000790;GO:0045892;GO:0047485;GO:0070742	nucleic acid binding;nucleus;nuclear speck;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;DNA binding;nuclear membrane;chromosome;protein binding;identical protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;negative regulation of transcription, DNA-templated;protein N-terminus binding;C2H2 zinc finger domain binding	Chromosome;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ9	positive	TMEM222	ENSG00000186501	COQ9	1	COQ9	1	0.00199269197782681	WBGene00019221	WBGene00019221(1)			GO:0016020;GO:0016021	membrane;integral component of membrane	Alternative splicing;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ9	positive	ABCB8	ENSG00000197150	COQ9	1	COQ9	1	0.00199269197782681	WBGene00001816;WBGene00001811;WBGene00001813;WBGene00001817;WBGene00001818	WBGene00004003(0);WBGene00003995(0);WBGene00004000(0);WBGene00004001(0);WBGene00004002(0);WBGene00001817(0);WBGene00001818(0);WBGene00004008(0);WBGene00004006(0)			GO:0016020;GO:0016021;GO:0055085;GO:0005634;GO:0000166;GO:0005524;GO:0005730;GO:0005739;GO:0005743;GO:0016887;GO:0042626;GO:0031966;GO:0043190	integral component of membrane;ATP binding;transmembrane transport;ATPase-coupled transmembrane transporter activity;ATPase activity;membrane;nucleotide binding;nucleoplasm;nucleolus;mitochondrion;mitochondrial inner membrane;ion transport;potassium ion transport;potassium ion transmembrane transport;protein binding;mitochondrial membrane;mitochondrial ATP-gated potassium channel complex;ATP-binding cassette (ABC) transporter complex	3D-structure;ATP-binding;Alternative splicing;Ion transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Polymorphism;Potassium;Potassium transport;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-382556;R-HSA-1369007	Transport of small molecules;ABC-family proteins mediated transport;Mitochondrial ABC transporters
COQ9	positive	ZNF627	ENSG00000198551	COQ9	1	COQ9	1	0.00199269197782681	WBGene00044651;WBGene00001223;WBGene00021931				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0005515;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding;regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	CDPF1	ENSG00000205643	COQ9	1	COQ9	1	0.00199269197782681		WBGene00008434(0);WBGene00271706(0)			GO:0005515	protein binding	Polymorphism;Reference proteome		
COQ9	positive	NISCH	ENSG00000010322	COQ9	1	COQ9	1	0.00354647602847347	WBGene00008750	WBGene00008750(0)			GO:0005737;GO:0016020;GO:0005886;GO:0005515;GO:0006915;GO:0035091;GO:0042802;GO:0005768;GO:0005769;GO:0005178;GO:0019901;GO:0055037;GO:0005829;GO:0006006;GO:0008217;GO:0016601;GO:0030036;GO:0030336;GO:0032228;GO:0048243	protein binding;phosphatidylinositol binding;integrin binding;cytoplasm;membrane;endosome;plasma membrane;apoptotic process;identical protein binding;early endosome;protein kinase binding;recycling endosome;cytosol;glucose metabolic process;regulation of blood pressure;Rac protein signal transduction;actin cytoskeleton organization;negative regulation of cell migration;regulation of synaptic transmission, GABAergic;norepinephrine secretion	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell membrane;Coiled coil;Cytoplasm;Endosome;Leucine-rich repeat;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat		
COQ9	positive	LYPLA2	ENSG00000011009	COQ9	1	COQ9	1	0.00354647602847347	WBGene00010564	WBGene00010564(0)			GO:0005737;GO:0016787;GO:0006629;GO:0006631;GO:0008474;GO:0002084;GO:0005795;GO:0005829;GO:0045296;GO:0070062;GO:0007411;GO:0052689	hydrolase activity;cytoplasm;lipid metabolic process;fatty acid metabolic process;palmitoyl-(protein) hydrolase activity;protein depalmitoylation;prostaglandin catabolic process;Golgi stack;cytosol;cadherin binding;extracellular exosome;axon guidance;carboxylic ester hydrolase activity;lysophospholipase activity;acylglycerol catabolic process	3D-structure;Cytoplasm;Fatty acid metabolism;Hydrolase;Lipid metabolism;Lipoprotein;Palmitate;Phosphoprotein;Reference proteome	R-HSA-1266738;R-HSA-373760;R-HSA-422475	Developmental Biology;L1CAM interactions;Axon guidance
COQ9	positive	PICK1	ENSG00000100151	COQ9	1	COQ9	1	0.00354647602847347	WBGene00013317	WBGene00013317(1)		Male infertility due to globozoospermia	GO:0005737;GO:0016020;GO:0046872;GO:0005829;GO:0005739;GO:0003779;GO:0005794;GO:0005886;GO:0019904;GO:0005856;GO:0005515;GO:0016235;GO:0048471;GO:0030054;GO:0045202;GO:0045211;GO:0006886;GO:0043113;GO:0043005;GO:0051015;GO:0006890;GO:0014069;GO:0008022;GO:0005543;GO:0008021;GO:0005102;GO:0019899;GO:0006468;GO:0030666;GO:0042734;GO:0007205;GO:0032588;GO:0042149;GO:0005080;GO:0001664;GO:0043046;GO:0002092;GO:0098842;GO:0034316;GO:0021782;GO:0015844;GO:0060292;GO:0097061;GO:0071933;GO:0036294;GO:0042802;GO:0043045;GO:0045161;GO:0097062	protein binding;protein domain specific binding;cytoplasm;membrane;metal ion binding;cytosol;mitochondrion;actin binding;Golgi apparatus;cytoskeleton;plasma membrane;aggresome;perinuclear region of cytoplasm;cell junction;synapse;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;intracellular protein transport;receptor clustering;neuron projection;actin filament binding;postsynaptic density;protein C-terminus binding;phospholipid binding;synaptic vesicle;signaling receptor binding;enzyme binding;protein phosphorylation;endocytic vesicle membrane;presynaptic membrane;protein kinase C-activating G protein-coupled receptor signaling pathway;trans-Golgi network membrane;cellular response to glucose starvation;protein kinase C binding;G protein-coupled receptor binding;DNA methylation involved in gamete generation;Arp2/3 complex binding;positive regulation of receptor internalization;postsynaptic early endosome;negative regulation of Arp2/3 complex-mediated actin nucleation;glial cell development;membrane curvature sensor activity;regulation of Arp2/3 complex-mediated actin nucleation;monoamine transport;long-term synaptic depression;dendritic spine organization;cellular response to decreased oxygen levels;identical protein binding;DNA methylation involved in embryo development;neuronal ion channel clustering;regulation of insulin secretion;dendritic spine maintenance	3D-structure;Actin-binding;Alternative splicing;Calcium;Cell junction;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Metal-binding;Palmitate;Phosphoprotein;Reference proteome;Synapse;Synaptosome;Zinc	R-HSA-109582;R-HSA-202733;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-399719;R-HSA-399721;R-HSA-416993	Hemostasis;Cell surface interactions at the vascular wall;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
COQ9	positive	POLR3H	ENSG00000100413	COQ9	1	COQ9	1	0.00354647602847347	WBGene00014111	WBGene00014111(1)			GO:0005634;GO:0043231;GO:0005813;GO:0005654;GO:0003677;GO:0006351;GO:0003899;GO:0002376;GO:0045087;GO:0005666;GO:0051607;GO:0005829;GO:0001056;GO:0032481;GO:0006383;GO:0006384;GO:0006139	DNA binding;DNA-directed 5'-3' RNA polymerase activity;transcription, DNA-templated;nucleus;intracellular membrane-bounded organelle;nucleoplasm;centrosome;immune system process;innate immune response;RNA polymerase III complex;defense response to virus;cytosol;positive regulation of type I interferon production;transcription by RNA polymerase III;transcription initiation from RNA polymerase III promoter;nucleobase-containing compound metabolic process	Alternative splicing;Antiviral defense;DNA-directed RNA polymerase;Immunity;Innate immunity;Nucleus;Reference proteome;Transcription	R-HSA-168249;R-HSA-168256;R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-76071;R-HSA-73980;R-HSA-1834949;R-HSA-73780	Innate Immune System;Immune System;Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Termination;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation
COQ9	positive	COG4	ENSG00000103051	COQ9	1	COQ9	1	0.00354647602847347	WBGene00021784	WBGene00021784(1)		COG4-CDG;Microcephalic osteodysplastic dysplasia Saul-Wilson type;COG4-CDG;SAUL-WILSON SYNDROME;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIj;SAUL-WILSON SYNDROME	GO:0005737;GO:0016020;GO:0015031;GO:0005794;GO:0005829;GO:0005515;GO:0000139;GO:0017119;GO:0007030;GO:0006890;GO:0032588;GO:0006888;GO:0048213	cytoplasm;membrane;protein transport;Golgi apparatus;cytosol;protein binding;Golgi membrane;Golgi transport complex;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Golgi organization;trans-Golgi network membrane;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi vesicle prefusion complex stabilization	3D-structure;Acetylation;Alternative splicing;Congenital disorder of glycosylation;Cytoplasm;Disease mutation;Dwarfism;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-6811438;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network
COQ9	positive	CPLANE2	ENSG00000132881	COQ9	1	COQ9	1	0.00354647602847347					GO:0005737;GO:0015031;GO:0000166;GO:0005654;GO:0003924;GO:0005525;GO:0006887;GO:0005856;GO:0042995;GO:0005515;GO:0005929;GO:0036064;GO:0060271;GO:0030030;GO:0034613;GO:0017157;GO:0031338	GTP binding;GTPase activity;cytoplasm;protein transport;nucleotide binding;nucleoplasm;cytoskeleton;exocytosis;cell projection;protein binding;cilium;ciliary basal body;cilium assembly;cell projection organization;cellular protein localization;regulation of exocytosis;regulation of vesicle fusion	Cell projection;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Exocytosis;GTP-binding;Nucleotide-binding;Polymorphism;Protein transport;Reference proteome;Transport		
COQ9	positive	SHROOM2	ENSG00000146950	COQ9	1	COQ9	1	0.00354647602847347					GO:0005737;GO:0016020;GO:0003779;GO:0051015;GO:0005886;GO:0005856;GO:0005515;GO:0035725;GO:0007275;GO:0030054;GO:0005874;GO:0005923;GO:0070062;GO:0030864;GO:0016477;GO:0016324;GO:0005912;GO:0030036;GO:0032401;GO:0045176;GO:0007015;GO:0008013;GO:0005913;GO:0043296;GO:0007420;GO:0048593;GO:0015280;GO:0002089;GO:0008057;GO:0032438;GO:0043010;GO:0043482;GO:0043583;GO:0005623	protein binding;actin filament binding;establishment of melanosome localization;apical protein localization;cell;cytoplasm;membrane;actin binding;cytoskeleton;plasma membrane;sodium ion transmembrane transport;multicellular organism development;cell junction;microtubule;bicellular tight junction;extracellular exosome;cell migration;apical plasma membrane;adherens junction;actin cytoskeleton organization;actin filament organization;cortical actin cytoskeleton;beta-catenin binding;apical junction complex;brain development;camera-type eye morphogenesis;ligand-gated sodium channel activity;lens morphogenesis in camera-type eye;eye pigment granule organization;melanosome organization;camera-type eye development;cellular pigment accumulation;ear development	3D-structure;Actin-binding;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Developmental protein;Membrane;Microtubule;Phosphoprotein;Polymorphism;Reference proteome;Tight junction		
COQ9	positive	TMEM143	ENSG00000161558	COQ9	1	COQ9	1	0.00354647602847347					GO:0003674;GO:0008150;GO:0016020;GO:0016021;GO:0005739	molecular_function;biological_process;membrane;integral component of membrane;mitochondrion	Alternative splicing;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ9	positive	CES2	ENSG00000172831	COQ9	1	COQ9	1	0.00354647602847347	WBGene00001578	WBGene00013875(0);WBGene00013874(0);WBGene00013873(0);WBGene00011364(0);WBGene00011362(0);WBGene00006412(0);WBGene00020688(0);WBGene00016595(0);WBGene00015284(0);WBGene00015279(0);WBGene00016862(0);WBGene00015071(0);WBGene00015067(0);WBGene00016863(0);WBGene00018958(0);WBGene00007695(0);WBGene00007692(0);WBGene00007691(0);WBGene00007693(0);WBGene00008451(0);WBGene00000038(0);WBGene00000037(0);WBGene00001578(0)			GO:0005783;GO:0016787;GO:0005615;GO:0005788;GO:0052689;GO:0006805;GO:0047374;GO:0080030;GO:0006693;GO:0009056	endoplasmic reticulum;hydrolase activity;extracellular space;endoplasmic reticulum lumen;carboxylic ester hydrolase activity;xenobiotic metabolic process;methylumbelliferyl-acetate deacetylase activity;methyl indole-3-acetate esterase activity;prostaglandin metabolic process;catabolic process	Alternative initiation;Alternative splicing;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Hydrolase;Polymorphism;Pyrrolidone carboxylic acid;Reference proteome;Serine esterase;Signal	R-HSA-1430728;R-HSA-211859;R-HSA-211945	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
COQ9	positive	DCAKD	ENSG00000172992	COQ9	1	COQ9	1	0.00354647602847347	WBGene00011500	WBGene00011500(0)			GO:0016020;GO:0000166;GO:0005524;GO:0016310;GO:0015937;GO:0004140	ATP binding;dephospho-CoA kinase activity;coenzyme A biosynthetic process;membrane;nucleotide binding;phosphorylation	ATP-binding;Alternative splicing;Nucleotide-binding;Polymorphism;Reference proteome		
COQ9	positive	FIZ1	ENSG00000179943	COQ9	1	COQ9	1	0.00354647602847347	WBGene00013240				GO:0003676;GO:0005634;GO:0005737;GO:0046872;GO:0030971;GO:0001934	nucleic acid binding;nucleus;cytoplasm;metal ion binding;receptor tyrosine kinase binding;positive regulation of protein phosphorylation	Acetylation;Cytoplasm;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ9	positive	ZBTB7C	ENSG00000184828	COQ9	1	COQ9	1	0.00354647602847347	WBGene00021846;WBGene00012317				GO:0003676;GO:0046872;GO:0003674;GO:0005575;GO:0008285;GO:0005515;GO:0045600;GO:0045944;GO:1903025;GO:0005634	protein binding;nucleic acid binding;metal ion binding;molecular_function;cellular_component;negative regulation of cell population proliferation;positive regulation of fat cell differentiation;positive regulation of transcription by RNA polymerase II;regulation of RNA polymerase II regulatory region sequence-specific DNA binding;nucleus	Metal-binding;Reference proteome;Repeat;Tumor suppressor;Zinc;Zinc-finger		
COQ9	positive	ZKSCAN3	ENSG00000189298	COQ9	1	COQ9	1	0.00354647602847347	WBGene00044651				GO:0003676;GO:0005634;GO:0005737;GO:0046872;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0006914;GO:0045893;GO:0043565;GO:0000978;GO:0001227;GO:0000122;GO:0003682;GO:0045892;GO:0007040;GO:0010507;GO:2000773;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;DNA binding;DNA-binding transcription factor activity;protein binding;autophagy;positive regulation of transcription, DNA-templated;sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;chromatin binding;negative regulation of transcription, DNA-templated;lysosome organization;negative regulation of autophagy;negative regulation of cellular senescence	Alternative splicing;Autophagy;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	SULT1A1	ENSG00000196502	COQ9	1	COQ9	1	0.00354647602847347	WBGene00013748				GO:0005737;GO:0016740;GO:0006629;GO:0008202;GO:0005515;GO:0008146;GO:0006805;GO:0005829;GO:0050294;GO:0050427;GO:0009308;GO:0051923;GO:0004062;GO:0006068;GO:0009812;GO:0006584;GO:0008210;GO:0047894;GO:0016021	sulfotransferase activity;cytoplasm;transferase activity;lipid metabolic process;steroid metabolic process;protein binding;xenobiotic metabolic process;catecholamine metabolic process;cytosol;steroid sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;amine metabolic process;sulfation;aryl sulfotransferase activity;ethanol catabolic process;flavonoid metabolic process;estrogen metabolic process;flavonol 3-sulfotransferase activity;integral component of membrane	3D-structure;Alternative splicing;Catecholamine metabolism;Cytoplasm;Direct protein sequencing;Lipid metabolism;Phosphoprotein;Polymorphism;Reference proteome;Steroid metabolism;Transferase	R-HSA-1430728;R-HSA-156580;R-HSA-211859;R-HSA-156584	Metabolism;Phase II - Conjugation of compounds;Biological oxidations;Cytosolic sulfonation of small molecules
COQ9	positive	ZNF785	ENSG00000197162	COQ9	1	COQ9	1	0.00354647602847347	WBGene00044651	WBGene00011066(0);WBGene00013734(0)			GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0005515;GO:0003700;GO:0043565;GO:0005622	nucleic acid binding;regulation of transcription, DNA-templated;nucleus;metal ion binding;DNA binding;protein binding;DNA-binding transcription factor activity;sequence-specific DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	SH3BP1	ENSG00000100092	COQ9	1	COQ9	1	0.00611253005771029	WBGene00021324;WBGene00006406	WBGene00021324(0)			GO:0005634;GO:0005737;GO:0007165;GO:0005829;GO:0000145;GO:0042995;GO:0005515;GO:0030054;GO:0005096;GO:0005923;GO:0043547;GO:0030027;GO:0031252;GO:0001891;GO:0032956;GO:0007015;GO:0016477;GO:0005912;GO:0017124;GO:0034329;GO:0045198;GO:0006909;GO:0071526;GO:0030215;GO:0048365;GO:0030834;GO:0051058;GO:0006911;GO:0043535	nucleus;cytoplasm;signal transduction;cytosol;exocyst;cell projection;protein binding;cell junction;GTPase activator activity;bicellular tight junction;positive regulation of GTPase activity;lamellipodium;cell leading edge;phagocytic cup;regulation of actin cytoskeleton organization;actin filament organization;cell migration;adherens junction;SH3 domain binding;cell junction assembly;establishment of epithelial cell apical/basal polarity;phagocytosis;semaphorin-plexin signaling pathway;semaphorin receptor binding;Rac GTPase binding;regulation of actin filament depolymerization;negative regulation of small GTPase mediated signal transduction;phagocytosis, engulfment;regulation of blood vessel endothelial cell migration;regulation of Rac protein signal transduction	3D-structure;Alternative initiation;Alternative splicing;Cell junction;Cell projection;Cytoplasm;GTPase activation;Nucleus;Phagocytosis;Phosphoprotein;Polymorphism;Reference proteome;SH3-binding;Tight junction		
COQ9	positive	ZNF500	ENSG00000103199	COQ9	1	COQ9	1	0.00611253005771029	WBGene00013970;WBGene00000483				GO:0003676;GO:0005634;GO:0046872;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005622	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;cytosol;DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	DDX49	ENSG00000105671	COQ9	1	COQ9	1	0.00611253005771029	WBGene00019219	WBGene00019219(0)			GO:0003676;GO:0003723;GO:0000166;GO:0005524;GO:0016787;GO:0004386;GO:0003724;GO:0005634;GO:0005654;GO:0006364	ATP binding;nucleic acid binding;RNA binding;nucleotide binding;hydrolase activity;helicase activity;RNA helicase activity;nucleus;nucleoplasm;rRNA processing;positive regulation of cell growth;regulation of rRNA stability	ATP-binding;Alternative splicing;Helicase;Hydrolase;Nucleotide-binding;Polymorphism;RNA-binding;Reference proteome	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ9	positive	ARMC6	ENSG00000105676	COQ9	1	COQ9	1	0.00611253005771029					GO:0005829;GO:0002244;GO:0005515	protein binding;cytosol;hematopoietic progenitor cell differentiation	Alternative splicing;Phosphoprotein;Reference proteome;Repeat		
COQ9	positive	RECQL5	ENSG00000108469	COQ9	1	COQ9	1	0.00611253005771029	WBGene00004322;WBGene00001865;WBGene00006944;WBGene00019334	WBGene00004322(0)			GO:0003676;GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0051301;GO:0006281;GO:0006974;GO:0007049;GO:0004386;GO:0006260;GO:0003678;GO:0006310;GO:0005654;GO:0032508;GO:0051304;GO:0000278;GO:0000724;GO:0034244;GO:0009378;GO:0006268;GO:0005694;GO:0000993;GO:0006259;GO:0016591;GO:0035690;GO:0072757;GO:1990414;GO:2000042	ATP binding;nucleic acid binding;DNA recombination;helicase activity;nucleus;cytoplasm;nucleotide binding;nucleoplasm;cytosol;hydrolase activity;cell division;DNA repair;cellular response to DNA damage stimulus;cell cycle;DNA replication;DNA helicase activity;chromosome separation;mitotic cell cycle;double-strand break repair via homologous recombination;DNA duplex unwinding;negative regulation of transcription elongation from RNA polymerase II promoter;four-way junction helicase activity;3'-5' DNA helicase activity;DNA unwinding involved in DNA replication;chromosome;RNA polymerase II complex binding;DNA metabolic process;RNA polymerase II, holoenzyme;cellular response to drug;cellular response to camptothecin;replication-born double-strand break repair via sister chromatid exchange;negative regulation of double-strand break repair via homologous recombination	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Cytoplasm;DNA damage;DNA repair;DNA replication;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ9	positive	NDUFS7	ENSG00000115286	COQ9	1	COQ9	1	0.00611253005771029	WBGene00012376	WBGene00012376(0)		Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I DEFICIENCY;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 3	GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0070469;GO:0051536;GO:0051539;GO:0008137;GO:0009060;GO:0005515;GO:0032981;GO:0005759;GO:0048038;GO:0003954;GO:0005747;GO:0006120;GO:0016655;GO:0015990;GO:0002020;GO:0043005;GO:0043025;GO:0097060	oxidation-reduction process;quinone binding;NADH dehydrogenase (ubiquinone) activity;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;metal ion binding;oxidoreductase activity;mitochondrion;respirasome;protein binding;aerobic respiration;mitochondrial respiratory chain complex I assembly;mitochondrial matrix;NADH dehydrogenase activity;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;electron transport coupled proton transport;protease binding;neuron projection;neuronal cell body;synaptic membrane	3D-structure;4Fe-4S;Alternative splicing;Disease mutation;Electron transport;Hydroxylation;Iron;Iron-sulfur;Leigh syndrome;Metal-binding;Mitochondrion;NAD;Oxidoreductase;Polymorphism;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transit peptide;Translocase;Transport;Ubiquinone	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ9	positive	COQ8B	ENSG00000123815	COQ9	1	COQ9	1	0.00611253005771029	WBGene00000767	WBGene00000767(0)		Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Nephrotic syndrome type 9	GO:0005737;GO:0016020;GO:0016021;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005739;GO:0006468;GO:0005829;GO:0005886;GO:0006744;GO:0031966;GO:0031314;GO:0021692	cytoplasm;membrane;integral component of membrane;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;mitochondrion;protein phosphorylation;cytosol;plasma membrane;ubiquinone biosynthetic process;mitochondrial membrane;extrinsic component of mitochondrial inner membrane;cerebellar Purkinje cell layer morphogenesis	ATP-binding;Alternative splicing;Cell membrane;Cytoplasm;Disease mutation;Kinase;Membrane;Mitochondrion;Nucleotide-binding;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix		
COQ9	positive	NECAB3	ENSG00000125967	COQ9	1	COQ9	1	0.00611253005771029					GO:0005634;GO:0005737;GO:0005794;GO:0046872;GO:0005789;GO:0005509;GO:0005515;GO:0005783;GO:0000137;GO:0009306;GO:0042984;GO:0019538	calcium ion binding;nucleus;cytoplasm;Golgi apparatus;metal ion binding;endoplasmic reticulum membrane;protein binding;endoplasmic reticulum;Golgi cis cisterna;protein secretion;regulation of amyloid precursor protein biosynthetic process;protein metabolic process	Alternative splicing;Calcium;Golgi apparatus;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome		
COQ9	positive	SAMD10	ENSG00000130590	COQ9	1	COQ9	1	0.00611253005771029		WBGene00044341(0)			GO:0005515	protein binding	Reference proteome		
COQ9	positive	C19orf57	ENSG00000132016	COQ9	1	COQ9	1	0.00611253005771029					GO:0005515;GO:0007275;GO:0003674;GO:0005575	protein binding;multicellular organism development;molecular_function;cellular_component	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ9	positive	ARFIP2	ENSG00000132254	COQ9	1	COQ9	1	0.00611253005771029	WBGene00010040	WBGene00010040(0)			GO:0005737;GO:0005886;GO:0019904;GO:0005515;GO:0042802;GO:0006886;GO:0005829;GO:0045296;GO:0005938;GO:0030036;GO:0005543;GO:0001726;GO:0005525;GO:0030032;GO:0007264;GO:0030742;GO:0032588;GO:0048365;GO:0031529;GO:0070273	protein domain specific binding;cytoplasm;membrane;Golgi apparatus;plasma membrane;protein binding;autophagy;identical protein binding;intracellular protein transport;cytosol;cadherin binding;cell cortex;actin cytoskeleton organization;phospholipid binding;ruffle;GTP binding;lamellipodium assembly;small GTPase mediated signal transduction;GTP-dependent protein binding;trans-Golgi network membrane;Rac GTPase binding;ruffle organization;phosphatidylinositol-4-phosphate binding;membrane curvature sensor activity;regulation of Arp2/3 complex-mediated actin nucleation	3D-structure;Alternative splicing;Autophagy;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-6811440	Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Retrograde transport at the Trans-Golgi-Network
COQ9	positive	LRRC27	ENSG00000148814	COQ9	1	COQ9	1	0.00611253005771029					GO:0005515	protein binding	Alternative splicing;Coiled coil;Leucine-rich repeat;Polymorphism;Reference proteome;Repeat		
COQ9	positive	EML3	ENSG00000149499	COQ9	1	COQ9	1	0.00611253005771029	WBGene00001248				GO:0005515;GO:0005737;GO:0005856;GO:0005874;GO:0000226;GO:0072686;GO:0008017	protein binding;cytoplasm;cytoskeleton;microtubule;microtubule cytoskeleton organization;mitotic spindle;microtubule binding	Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Microtubule;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ9	positive	ZNF599	ENSG00000153896	COQ9	1	COQ9	1	0.00611253005771029	WBGene00021931;WBGene00001223			NOT IN OMIM	GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0005515;GO:0003700;GO:0043565;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding;DNA-binding transcription factor activity;sequence-specific DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	positive	RGS12	ENSG00000159788	COQ9	1	COQ9	1	0.00611253005771029	WBGene00004347;WBGene00004350;WBGene00004349				GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0007165;GO:0030695;GO:0050790;GO:0043547;GO:0042995;GO:0030054;GO:0045202;GO:0005096;GO:0030425;GO:0005886;GO:0007186;GO:0016363;GO:0009968;GO:0003924;GO:0008277;GO:0000794;GO:0005515	protein binding;signal transduction;GTPase regulator activity;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;regulation of catalytic activity;positive regulation of GTPase activity;cell projection;cell junction;GTPase activator activity;synapse;dendrite;plasma membrane;G protein-coupled receptor signaling pathway;nuclear matrix;negative regulation of signal transduction;GTPase activity;regulation of G protein-coupled receptor signaling pathway;condensed nuclear chromosome	3D-structure;Alternative splicing;Cell junction;Cell projection;Cytoplasm;GTPase activation;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Signal transduction inhibitor;Synapse;Transcription;Ubl conjugation	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
COQ9	positive	C19orf47	ENSG00000160392	COQ9	1	COQ9	1	0.00611253005771029	WBGene00010002	WBGene00010002(0)			GO:0005654;GO:0005515	nucleoplasm;protein binding	Alternative splicing;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation		
COQ9	positive	EMC10	ENSG00000161671	COQ9	1	COQ9	1	0.00611253005771029	WBGene00012829				GO:0016020;GO:0016021;GO:0005576;GO:0001525;GO:0045766;GO:0010595;GO:1900745;GO:0072546;GO:0001938	membrane;integral component of membrane;extracellular region;angiogenesis;positive regulation of angiogenesis;positive regulation of endothelial cell migration;positive regulation of p38MAPK cascade;ER membrane protein complex;positive regulation of endothelial cell proliferation	Alternative splicing;Angiogenesis;Glycoprotein;Membrane;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix		
COQ9	positive	HDAC11	ENSG00000163517	COQ9	1	COQ9	1	0.00611253005771029	WBGene00007953	WBGene00007953(1)	TNFSF4		GO:0016787;GO:0005634;GO:0006325;GO:0014003;GO:0005515;GO:0004407;GO:0032041;GO:0070932;GO:0000118;GO:0008134;GO:0005886;GO:0016575	hydrolase activity;nucleus;chromatin organization;protein binding;histone deacetylase activity;NAD-dependent histone deacetylase activity (H3-K14 specific);histone H3 deacetylation;histone deacetylase complex;transcription factor binding;plasma membrane;histone deacetylation;oligodendrocyte development	Alternative splicing;Chromatin regulator;Hydrolase;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-2122947;R-HSA-350054	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Diseases of signal transduction;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway
COQ9	positive	HEXD	ENSG00000169660	COQ9	1	COQ9	1	0.00611253005771029	WBGene00012663;WBGene00015767;WBGene00013497;WBGene00021766	WBGene00015767(0);WBGene00012663(0);WBGene00013497(0);WBGene00021766(0)			GO:0005634;GO:0005737;GO:0016787;GO:0005975;GO:0008152;GO:0004553;GO:0016798;GO:0004563;GO:0102148;GO:0015929;GO:1903561	carbohydrate metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds;hexosaminidase activity;nucleus;cytoplasm;hydrolase activity;metabolic process;hydrolase activity, acting on glycosyl bonds;beta-N-acetylhexosaminidase activity;N-acetyl-beta-D-galactosaminidase activity;extracellular vesicle	Alternative splicing;Cytoplasm;Disulfide bond;Glycosidase;Hydrolase;Nucleus;Polymorphism;Reference proteome		
COQ9	positive	NDUFA3	ENSG00000170906	COQ9	1	COQ9	1	0.00611253005771029					GO:0005743;GO:0005747;GO:0016020;GO:0016021;GO:0055114;GO:0005739;GO:0070469;GO:0032981;GO:0008137;GO:0006120	mitochondrial inner membrane;mitochondrial respiratory chain complex I;membrane;integral component of membrane;oxidation-reduction process;mitochondrion;respirasome;mitochondrial respiratory chain complex I assembly;NADH dehydrogenase (ubiquinone) activity;mitochondrial electron transport, NADH to ubiquinone	3D-structure;Acetylation;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ9	positive	PWWP2B	ENSG00000171813	COQ9	1	COQ9	1	0.00611253005771029					GO:0005654;GO:0005515	nucleoplasm;protein binding	3D-structure;Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ9	positive	QTRT1	ENSG00000213339	COQ9	1	COQ9	1	0.00611253005771029	WBGene00006566	WBGene00006566(1)			GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0008033;GO:0016757;GO:0005739;GO:0042803;GO:0006400;GO:0005741;GO:0016763;GO:0032991;GO:0046982;GO:0008479;GO:0101030;GO:0005634	transferase activity, transferring pentosyl groups;tRNA modification;queuine tRNA-ribosyltransferase activity;tRNA-guanine transglycosylation;cytoplasm;membrane;metal ion binding;transferase activity;tRNA processing;transferase activity, transferring glycosyl groups;mitochondrion;protein homodimerization activity;mitochondrial outer membrane;protein-containing complex;protein heterodimerization activity;nucleus	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Glycosyltransferase;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Reference proteome;Transferase;Zinc;tRNA processing	R-HSA-6782315;R-HSA-72306;R-HSA-8953854	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
COQ9	positive	ZNF345	ENSG00000251247	COQ9	1	COQ9	1	0.00611253005771029	WBGene00021931				GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0006366;GO:0000122;GO:0006359;GO:0006383	nucleic acid binding;nucleus;metal ion binding;DNA binding;regulation of gene expression;transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase III;transcription by RNA polymerase III	DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ9	negative	ZNF267	ENSG00000185947	COQ9	1	COQ9	1	0.0019644493679456	WBGene00021931;WBGene00001223				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0006357;GO:0000981;GO:0007275;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding;DNA-binding transcription factor activity;multicellular organism development	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ9	negative	RIPK2	ENSG00000104312	COQ9	1	COQ9	1	0.00451730811002737					GO:0045944;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0042981;GO:0018108;GO:0005856;GO:0005515;GO:0004715;GO:0006915;GO:0002376;GO:0045087;GO:0002250;GO:0042802;GO:0043065;GO:0005739;GO:0050852;GO:0001961;GO:0002827;GO:0007249;GO:0031663;GO:0032722;GO:0032729;GO:0032743;GO:0032755;GO:0032760;GO:0032874;GO:0033091;GO:0034142;GO:0042098;GO:0043123;GO:0043330;GO:0045627;GO:0046330;GO:0046641;GO:0050830;GO:0051092;GO:0070374;GO:0070427;GO:0070431;GO:0070555;GO:0070671;GO:0070673;GO:0071222;GO:0071223;GO:0071224;GO:1904417;GO:0050700;GO:0010800;GO:0033138;GO:0070498;GO:0032991;GO:0050718;GO:0031398;GO:0042803;GO:0005102;GO:0006954;GO:0007165;GO:0032727;GO:0032728;GO:0032735;GO:0032092;GO:0031982;GO:0089720;GO:0007254;GO:0043066;GO:0050731;GO:0000187;GO:0070423;GO:0030274;GO:0010942;GO:0034134;GO:0071225;GO:0097202	ATP binding;cytoplasm;regulation of apoptotic process;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;positive regulation of apoptotic process;positive regulation of transcription by RNA polymerase II;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;peptidyl-tyrosine phosphorylation;cytoskeleton;protein binding;non-membrane spanning protein tyrosine kinase activity;apoptotic process;immune system process;innate immune response;adaptive immune response;identical protein binding;mitochondrion;T cell receptor signaling pathway;positive regulation of cytokine-mediated signaling pathway;positive regulation of T-helper 1 type immune response;I-kappaB kinase/NF-kappaB signaling;lipopolysaccharide-mediated signaling pathway;positive regulation of chemokine production;positive regulation of interferon-gamma production;positive regulation of interleukin-2 production;positive regulation of interleukin-6 production;positive regulation of tumor necrosis factor production;positive regulation of stress-activated MAPK cascade;positive regulation of immature T cell proliferation;toll-like receptor 4 signaling pathway;T cell proliferation;positive regulation of I-kappaB kinase/NF-kappaB signaling;response to exogenous dsRNA;positive regulation of T-helper 1 cell differentiation;positive regulation of JNK cascade;positive regulation of alpha-beta T cell proliferation;defense response to Gram-positive bacterium;positive regulation of NF-kappaB transcription factor activity;positive regulation of ERK1 and ERK2 cascade;nucleotide-binding oligomerization domain containing 1 signaling pathway;nucleotide-binding oligomerization domain containing 2 signaling pathway;response to interleukin-1;response to interleukin-12;response to interleukin-18;cellular response to lipopolysaccharide;cellular response to lipoteichoic acid;cellular response to peptidoglycan;positive regulation of xenophagy;CARD domain binding;positive regulation of peptidyl-threonine phosphorylation;positive regulation of peptidyl-serine phosphorylation;interleukin-1-mediated signaling pathway;protein-containing complex;positive regulation of interleukin-1 beta secretion;positive regulation of protein ubiquitination;protein homodimerization activity;signaling receptor binding;inflammatory response;signal transduction;positive regulation of interferon-alpha production;positive regulation of interferon-beta production;positive regulation of interleukin-12 production;positive regulation of protein binding;vesicle;caspase binding;JNK cascade;negative regulation of apoptotic process;positive regulation of peptidyl-tyrosine phosphorylation;activation of MAPK activity;nucleotide-binding oligomerization domain containing signaling pathway;LIM domain binding;positive regulation of cell death;toll-like receptor 2 signaling pathway;cellular response to muramyl dipeptide;activation of cysteine-type endopeptidase activity	3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Apoptosis;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-202403;R-HSA-202424;R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-193704;R-HSA-73887;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-5688426;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-450321;R-HSA-975871;R-HSA-168643;R-HSA-168638;R-HSA-193639;R-HSA-209543;R-HSA-445989;R-HSA-450302;R-HSA-5689896	Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Downstream TCR signaling;Metabolism of proteins;Post-translational protein modification;Signal Transduction;p75 NTR receptor-mediated signalling;Death Receptor Signalling;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Deubiquitination;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;MyD88 cascade initiated on plasma membrane;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;p75NTR signals via NF-kB;p75NTR recruits signalling complexes;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;activated TAK1 mediates p38 MAPK activation;Ovarian tumor domain proteases
COQ9	negative	SUCO	ENSG00000094975	COQ9	1	COQ9	1	0.00667665486352931	WBGene00020031	WBGene00020031(0)			GO:0016020;GO:0016021;GO:0005783;GO:0007275;GO:0032967;GO:0045669;GO:0046850;GO:0005791;GO:0005737;GO:0001503;GO:0030867	membrane;integral component of membrane;endoplasmic reticulum;multicellular organism development;positive regulation of collagen biosynthetic process;positive regulation of osteoblast differentiation;regulation of bone remodeling;rough endoplasmic reticulum;cytoplasm;ossification;rough endoplasmic reticulum membrane	Alternative splicing;Coiled coil;Developmental protein;Endoplasmic reticulum;Glycoprotein;Membrane;Osteogenesis;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ9	negative	SHOC2	ENSG00000108061	COQ9	1	COQ9	1	0.00667665486352931	WBGene00004929			NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR;Noonan-like syndrome with loose anagen hair;NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0019888;GO:0043666;GO:0005515;GO:0007265;GO:0019903;GO:0046579;GO:0008543;GO:0000164;GO:0008157	protein binding;nucleus;cytoplasm;nucleoplasm;cytosol;protein phosphatase regulator activity;regulation of phosphoprotein phosphatase activity;Ras protein signal transduction;protein phosphatase binding;positive regulation of Ras protein signal transduction;fibroblast growth factor receptor signaling pathway;protein phosphatase type 1 complex;protein phosphatase 1 binding	Alternative splicing;Cytoplasm;Disease mutation;Leucine-rich repeat;Nucleus;Reference proteome;Repeat		
COQ9	negative	ASAP1	ENSG00000153317	COQ9	1	COQ9	1	0.00667665486352931					GO:0005096;GO:0043547;GO:0005515;GO:0005737;GO:0016020;GO:0046872;GO:0060271;GO:0005829;GO:0045296;GO:0030030;GO:0031253;GO:1903527;GO:0002102;GO:0001786;GO:0005546;GO:0005547;GO:0061000;GO:0071803;GO:0043197	protein binding;GTPase activator activity;positive regulation of GTPase activity;cytoplasm;membrane;metal ion binding;cilium assembly;cytosol;cadherin binding;cell projection organization;cell projection membrane;positive regulation of membrane tubulation;podosome;phosphatidylserine binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-3,4,5-trisphosphate binding;negative regulation of dendritic spine development;positive regulation of podosome assembly;dendritic spine	3D-structure;ANK repeat;Alternative splicing;Cilium biogenesis/degradation;Cytoplasm;GTPase activation;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;Zinc;Zinc-finger	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5620916	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;VxPx cargo-targeting to cilium
COQ9	negative	CD47	ENSG00000196776	COQ9	1	COQ9	1	0.00667665486352931					GO:0071347;GO:0016020;GO:0016021;GO:0007155;GO:0005886;GO:0005515;GO:0050900;GO:0005887;GO:0050870;GO:0043312;GO:0035579;GO:0070821;GO:0008284;GO:0098609;GO:0022409;GO:0050766;GO:0009986;GO:0030198;GO:0045428;GO:0007229;GO:0034113;GO:0050729;GO:0070053;GO:0035696;GO:0086080;GO:0016477;GO:0051496;GO:0098632;GO:0032649;GO:0032675;GO:0032680;GO:0071346;GO:0071349;GO:0032653;GO:0032655;GO:1905450;GO:0070062;GO:0008228;GO:0009617	cellular response to interleukin-1;protein binding;membrane;integral component of membrane;cell adhesion;plasma membrane;leukocyte migration;integral component of plasma membrane;positive regulation of T cell activation;neutrophil degranulation;specific granule membrane;tertiary granule membrane;positive regulation of cell population proliferation;positive regulation of cell-cell adhesion;positive regulation of phagocytosis;cell surface;extracellular matrix organization;regulation of nitric oxide biosynthetic process;integrin-mediated signaling pathway;heterotypic cell-cell adhesion;positive regulation of inflammatory response;thrombospondin receptor activity;monocyte extravasation;protein binding involved in heterotypic cell-cell adhesion;cell migration;positive regulation of stress fiber assembly;cell-cell adhesion mediator activity;regulation of interferon-gamma production;regulation of interleukin-6 production;regulation of tumor necrosis factor production;cellular response to interferon-gamma;cellular response to interleukin-12;regulation of interleukin-10 production;regulation of interleukin-12 production;negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;extracellular exosome;inflammatory response;opsonization;response to bacterium;monocyte aggregation	3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Pyrrolidone carboxylic acid;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-1474244;R-HSA-216083;R-HSA-6798695;R-HSA-1500931;R-HSA-391160	Hemostasis;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Extracellular matrix organization;Integrin cell surface interactions;Neutrophil degranulation;Cell-Cell communication;Signal regulatory protein family interactions
COQ9	negative	DNM3	ENSG00000197959	COQ9	1	COQ9	1	0.00667665486352931	WBGene00001130;WBGene00001093				GO:0003924;GO:0005525;GO:0000166;GO:0005737;GO:0016787;GO:0005856;GO:0048471;GO:0005874;GO:0005886;GO:0016020;GO:0005515;GO:0045202;GO:0006897;GO:0070062;GO:0008017;GO:0014069;GO:0045211;GO:0043197;GO:0046847;GO:0030424;GO:0031410;GO:0000266;GO:0007416;GO:0016185;GO:0031623;GO:0099173;GO:0050803;GO:0098884;GO:0044327;GO:0098844;GO:0031798;GO:0031802;GO:0050998;GO:0099186;GO:0048488;GO:0051491;GO:0061001;GO:0061002;GO:1903423;GO:0001917;GO:0005794;GO:0043083;GO:0061828;GO:0061829;GO:0098793;GO:0098978	GTP binding;GTPase activity;cytoplasm;nucleotide binding;hydrolase activity;cytoskeleton;perinuclear region of cytoplasm;microtubule;plasma membrane;protein binding;endocytosis;membrane;synapse;membrane fusion;extracellular exosome;microtubule binding;postsynaptic density;postsynaptic membrane;dendritic spine;filopodium assembly;mitochondrial membrane;microtubule cytoskeleton;axon;cytoplasmic vesicle;organelle fission;mitochondrial fission;synapse assembly;synaptic vesicle budding from presynaptic endocytic zone membrane;receptor internalization;postsynapse organization;regulation of synapse structure or activity;postsynaptic neurotransmitter receptor internalization;dendritic spine head;postsynaptic endocytic zone membrane;type 1 metabotropic glutamate receptor binding;type 5 metabotropic glutamate receptor binding;nitric-oxide synthase binding;structural constituent of postsynapse;synaptic vesicle endocytosis;positive regulation of filopodium assembly;regulation of dendritic spine morphogenesis;negative regulation of dendritic spine morphogenesis;positive regulation of synaptic vesicle recycling;photoreceptor inner segment;Golgi apparatus;synaptic cleft;apical tubulobulbar complex;basal tubulobulbar complex;presynapse;glutamatergic synapse	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Endocytosis;GTP-binding;Hydrolase;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-199991;R-HSA-2132295;R-HSA-9006934;R-HSA-166016;R-HSA-168898;R-HSA-8856828;R-HSA-166520;R-HSA-187037;R-HSA-177504	Adaptive Immune System;Innate Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Membrane Trafficking;MHC class II antigen presentation;Signaling by Receptor Tyrosine Kinases;Toll Like Receptor 4 (TLR4) Cascade;Toll-like Receptor Cascades;Clathrin-mediated endocytosis;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Retrograde neurotrophin signalling
COQ9	negative	LYN	ENSG00000254087	COQ9	1	COQ9	1	0.00667665486352931	WBGene00005077				GO:0001934;GO:0005634;GO:0005737;GO:0016020;GO:0005794;GO:0043231;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0005886;GO:0005515;GO:0006974;GO:0004715;GO:0030218;GO:0048471;GO:0006954;GO:0045121;GO:0002376;GO:0045087;GO:0002250;GO:0038095;GO:0038096;GO:0050900;GO:0042629;GO:0030154;GO:0007169;GO:0005829;GO:0031234;GO:0070062;GO:0008285;GO:0002223;GO:0034136;GO:0034144;GO:0016032;GO:0008284;GO:0031175;GO:0044325;GO:0007165;GO:2000670;GO:0030168;GO:0001933;GO:0014068;GO:0048013;GO:0046777;GO:0005102;GO:0070667;GO:0033628;GO:0070373;GO:0030889;GO:0001932;GO:0033003;GO:0007596;GO:0031295;GO:0043407;GO:0070304;GO:0051272;GO:0042531;GO:0046579;GO:0060397;GO:1902961;GO:0097028;GO:0070372;GO:0031663;GO:0046875;GO:0018108;GO:0050777;GO:0001817;GO:0009725;GO:0042127;GO:0038083;GO:0043304;GO:0005161;GO:0005178;GO:0017124;GO:0019899;GO:0031625;GO:0043015;GO:0043208;GO:0044877;GO:0051219;GO:0140031;GO:0001782;GO:0002431;GO:0002513;GO:0002553;GO:0002576;GO:0002762;GO:0002768;GO:0002774;GO:0002902;GO:0006991;GO:0009636;GO:0009743;GO:0010976;GO:0014003;GO:0014070;GO:0030097;GO:0030335;GO:0031668;GO:0032868;GO:0034142;GO:0034605;GO:0035556;GO:0042327;GO:0042493;GO:0043200;GO:0043434;GO:0043552;GO:0045646;GO:0048678;GO:0050663;GO:0050707;GO:0050727;GO:0050853;GO:0050855;GO:0051279;GO:0060252;GO:0060369;GO:0070447;GO:0070668;GO:0071300;GO:0090025;GO:0090330;GO:1902532;GO:0005758;GO:0005913;GO:0014069;GO:0030061;GO:0031966;GO:0032991;GO:0034666;GO:0098978;GO:0099091	ATP binding;protein binding;protein phosphorylation;protein kinase activity;protein tyrosine kinase activity;positive regulation of protein phosphorylation;nucleus;cytoplasm;membrane;Golgi apparatus;intracellular membrane-bounded organelle;nucleotide binding;kinase activity;transferase activity;phosphorylation;plasma membrane;cellular response to DNA damage stimulus;non-membrane spanning protein tyrosine kinase activity;perinuclear region of cytoplasm;inflammatory response;membrane raft;immune system process;innate immune response;adaptive immune response;Fc-epsilon receptor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;leukocyte migration;mast cell granule;cell differentiation;transmembrane receptor protein tyrosine kinase signaling pathway;erythrocyte differentiation;cytosol;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome;negative regulation of cell population proliferation;stimulatory C-type lectin receptor signaling pathway;negative regulation of toll-like receptor 2 signaling pathway;negative regulation of toll-like receptor 4 signaling pathway;viral process;positive regulation of cell population proliferation;neuron projection development;regulation of cell population proliferation;ion channel binding;signal transduction;positive regulation of dendritic cell apoptotic process;platelet activation;negative regulation of protein phosphorylation;positive regulation of phosphatidylinositol 3-kinase signaling;ephrin receptor signaling pathway;protein autophosphorylation;signaling receptor binding;negative regulation of mast cell proliferation;regulation of cell adhesion mediated by integrin;negative regulation of ERK1 and ERK2 cascade;negative regulation of B cell proliferation;regulation of protein phosphorylation;regulation of mast cell activation;blood coagulation;T cell costimulation;negative regulation of MAP kinase activity;positive regulation of stress-activated protein kinase signaling cascade;positive regulation of cellular component movement;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of Ras protein signal transduction;growth hormone receptor signaling pathway via JAK-STAT;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;dendritic cell differentiation;regulation of ERK1 and ERK2 cascade;lipopolysaccharide-mediated signaling pathway;ephrin receptor binding;peptidyl-tyrosine phosphorylation;negative regulation of immune response;regulation of cytokine production;response to hormone;peptidyl-tyrosine autophosphorylation;regulation of mast cell degranulation;platelet-derived growth factor receptor binding;integrin binding;SH3 domain binding;enzyme binding;ubiquitin protein ligase binding;gamma-tubulin binding;glycosphingolipid binding;protein-containing complex binding;phosphoprotein binding;phosphorylation-dependent protein binding;B cell homeostasis;Fc receptor mediated stimulatory signaling pathway;tolerance induction to self antigen;histamine secretion by mast cell;platelet degranulation;negative regulation of myeloid leukocyte differentiation;immune response-regulating cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;regulation of B cell apoptotic process;response to sterol depletion;response to toxic substance;response to carbohydrate;positive regulation of neuron projection development;oligodendrocyte development;response to organic cyclic compound;hemopoiesis;positive regulation of cell migration;cellular response to extracellular stimulus;response to insulin;toll-like receptor 4 signaling pathway;cellular response to heat;intracellular signal transduction;positive regulation of phosphorylation;response to drug;response to amino acid;response to peptide hormone;positive regulation of phosphatidylinositol 3-kinase activity;regulation of erythrocyte differentiation;response to axon injury;cytokine secretion;regulation of cytokine secretion;regulation of inflammatory response;B cell receptor signaling pathway;regulation of B cell receptor signaling pathway;regulation of release of sequestered calcium ion into cytosol;positive regulation of glial cell proliferation;positive regulation of Fc receptor mediated stimulatory signaling pathway;positive regulation of oligodendrocyte progenitor proliferation;positive regulation of mast cell proliferation;cellular response to retinoic acid;regulation of monocyte chemotaxis;regulation of platelet aggregation;negative regulation of intracellular signal transduction;mitochondrial intermembrane space;postsynaptic density;mitochondrial crista;mitochondrial membrane;protein-containing complex;integrin alpha2-beta1 complex;glutamatergic synapse;postsynaptic specialization, intracellular component	3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Cell membrane;Cytoplasm;Golgi apparatus;Host-virus interaction;Immunity;Inflammatory response;Innate immunity;Kinase;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;SH2 domain;SH3 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-2029480;R-HSA-2029481;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-983695;R-HSA-983705;R-HSA-388841;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-1640170;R-HSA-1280215;R-HSA-449147;R-HSA-5621481;R-HSA-69278;R-HSA-9006934;R-HSA-76002;R-HSA-453279;R-HSA-512988;R-HSA-9006335;R-HSA-9027276;R-HSA-912631;R-HSA-2682334;R-HSA-3928662;R-HSA-114604;R-HSA-1433557;R-HSA-389356;R-HSA-69231;R-HSA-69236;R-HSA-1433559;R-HSA-982772;R-HSA-3928665;R-HSA-3928663;R-HSA-9027277;R-HSA-9027283;R-HSA-9027284;R-HSA-75892;R-HSA-5621575;R-HSA-210990;R-HSA-389513;R-HSA-5621480	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Costimulation by the CD28 family;Developmental Biology;Axon guidance;Signal Transduction;Cell Cycle;Cytokine Signaling in Immune system;Signaling by Interleukins;C-type lectin receptors (CLRs);Cell Cycle, Mitotic;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;Mitotic G1 phase and G1/S transition;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by Erythropoietin;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Regulation of signaling by CBL;EPH-Ephrin signaling;EPHB-mediated forward signaling;GPVI-mediated activation cascade;Signaling by SCF-KIT;CD28 co-stimulation;Cyclin D associated events in G1;G1 Phase;Regulation of KIT signaling;Growth hormone receptor signaling;EPH-ephrin mediated repulsion of cells;EPHA-mediated growth cone collapse;Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS;Platelet Adhesion to exposed collagen;CD209 (DC-SIGN) signaling;PECAM1 interactions;CTLA4 inhibitory signaling;Dectin-2 family
COQ9	negative	MCUB	ENSG00000005059	COQ9	1	COQ9	1	0.00970223179625307	WBGene00019296				GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0006811;GO:0031305;GO:0006816;GO:0031224;GO:0006851;GO:0051560;GO:0019855;GO:0034704;GO:1990246;GO:0036444	mitochondrial calcium ion homeostasis;membrane;integral component of membrane;intracellular membrane-bounded organelle;nucleoplasm;mitochondrion;mitochondrial inner membrane;ion transport;integral component of mitochondrial inner membrane;calcium ion transport;intrinsic component of membrane;mitochondrial calcium ion transmembrane transport;calcium channel inhibitor activity;calcium channel complex;uniplex complex;calcium import into the mitochondrion	Calcium;Calcium transport;Coiled coil;Ion transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-8949215;R-HSA-8949664	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
COQ9	negative	ATP2C1	ENSG00000017260	COQ9	1	COQ9	1	0.00970223179625307	WBGene00004063;WBGene00004736	WBGene00015338(0);WBGene00015660(0);WBGene00003153(0);WBGene00019875(0);WBGene00004063(0)		Familial benign chronic pemphigus;BENIGN CHRONIC PEMPHIGUS	GO:0016020;GO:0016021;GO:0005794;GO:0046872;GO:0000166;GO:0005524;GO:0006811;GO:1902600;GO:0000139;GO:0005388;GO:0006816;GO:0070588;GO:0071421;GO:0034220;GO:0005802;GO:0043123;GO:0008553;GO:0008544;GO:0006874;GO:0031532;GO:0015410;GO:0016339;GO:0032468;GO:0032472	integral component of membrane;ATP binding;calcium ion transport;calcium ion transmembrane transport;nucleotide binding;calcium transmembrane transporter activity, phosphorylative mechanism;membrane;Golgi apparatus;ion transport;cell;metal ion binding;proton transmembrane transport;Golgi membrane;ion transmembrane transport;trans-Golgi network;positive regulation of I-kappaB kinase/NF-kappaB signaling;manganese ion transmembrane transport;proton-exporting ATPase activity, phosphorylative mechanism;epidermis development;cellular calcium ion homeostasis;actin cytoskeleton reorganization;manganese transmembrane transporter activity, phosphorylative mechanism;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;Golgi calcium ion homeostasis;Golgi calcium ion transport	ATP-binding;Alternative splicing;Calcium;Calcium transport;Disease mutation;Golgi apparatus;Ion transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Polymorphism;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-983712;R-HSA-936837	Transport of small molecules;Ion channel transport;Ion transport by P-type ATPases
COQ9	negative	VRK2	ENSG00000028116	COQ9	1	COQ9	1	0.00970223179625307	WBGene00017895	WBGene00008088(0);WBGene00010692(0);WBGene00008883(0);WBGene00017725(0);WBGene00013868(0);WBGene00008464(0);WBGene00010719(0);WBGene00013744(0);WBGene00020071(0);WBGene00018122(0);WBGene00009402(0);WBGene00010874(0);WBGene00012169(0);WBGene00016673(0);WBGene00022705(0);WBGene00022032(0);WBGene00022102(0);WBGene00017895(0);WBGene00013979(0);WBGene00013978(0);WBGene00016541(0);WBGene00012637(0);WBGene00007791(0);WBGene00019556(0);WBGene00016513(0);WBGene00016765(0);WBGene00022108(0);WBGene00007335(0);WBGene00017050(0);WBGene00021639(0);WBGene00008423(0);WBGene00014007(0);WBGene00007448(0);WBGene00016946(0);WBGene00020381(0);WBGene00008662(0);WBGene00018839(0);WBGene00016963(0);WBGene00018202(0);WBGene00018203(0);WBGene00017714(0);WBGene00010555(0);WBGene00019642(0);WBGene00015893(0);WBGene00016111(0);WBGene00019119(0);WBGene00020580(0);WBGene00007269(0);WBGene00019561(0);WBGene00019562(0);WBGene00011283(0);WBGene00022707(0);WBGene00017803(0);WBGene00018123(0);WBGene00020072(0);WBGene00012731(0);WBGene00018745(0);WBGene00007777(0);WBGene00007049(0);WBGene00019459(0);WBGene00019086(0);WBGene00020223(0);WBGene00016388(0);WBGene00018004(0);WBGene00007305(0);WBGene00009324(0);WBGene00021109(0);WBGene00019769(0)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005783;GO:0005789;GO:0005739;GO:0005515;GO:0031966;GO:0016032;GO:0032991;GO:0018105;GO:0034599;GO:0046777;GO:0005635;GO:0043408;GO:0019901;GO:0019904;GO:2000659	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;membrane;integral component of membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;protein binding;mitochondrial membrane;viral process;protein-containing complex;peptidyl-serine phosphorylation;cellular response to oxidative stress;protein autophosphorylation;Wnt signaling pathway;nuclear envelope;regulation of MAPK cascade;protein kinase binding;protein domain specific binding;regulation of interleukin-1-mediated signaling pathway	3D-structure;ATP-binding;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Host-virus interaction;Kinase;Membrane;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Transmembrane;Transmembrane helix		
COQ9	negative	STAG2	ENSG00000101972	COQ9	1	COQ9	1	0.00970223179625307	WBGene00004738	WBGene00004738(0)		Xq25 microduplication syndrome;STAG2-related developmental delay with microcephaly and congenital anomalies;NEURODEVELOPMENTAL DISORDER X-LINKED WITH CRANIOFACIALABNORMALITIES	GO:0005634;GO:0016020;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0051321;GO:0007059;GO:0000775;GO:0005654;GO:0005829;GO:0003682;GO:0000785;GO:0016363;GO:0097431;GO:0007062;GO:1901673;GO:0008278	nucleus;membrane;cell division;chromosome;protein binding;cell cycle;meiotic cell cycle;chromosome segregation;chromosome, centromeric region;nucleoplasm;cytosol;chromatin binding;chromatin;nuclear matrix;mitotic spindle pole;sister chromatid cohesion;regulation of mitotic spindle assembly;cohesin complex	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Disease mutation;Meiosis;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69242;R-HSA-69278;R-HSA-2500257;R-HSA-68877;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-8939211;R-HSA-9006931;R-HSA-9018519;R-HSA-2468052;R-HSA-2470946;R-HSA-68884	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;S Phase;Cell Cycle, Mitotic;Resolution of Sister Chromatid Cohesion;Mitotic Prometaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis
COQ9	negative	TP53BP2	ENSG00000143514	COQ9	1	COQ9	1	0.00970223179625307	WBGene00000146	WBGene00000146(0)			GO:0048471;GO:0005737;GO:0005739;GO:0005634;GO:0005829;GO:0030054;GO:0005515;GO:0007049;GO:0006915;GO:0042802;GO:0005654;GO:0017124;GO:0007165;GO:0042981;GO:0045786;GO:1901796;GO:0005070;GO:1900740;GO:0051059;GO:0072332;GO:1900119;GO:0002039;GO:1901216	protein binding;perinuclear region of cytoplasm;cytoplasm;mitochondrion;nucleus;cytosol;cell junction;cell cycle;apoptotic process;identical protein binding;nucleoplasm;SH3 domain binding;signal transduction;regulation of apoptotic process;negative regulation of cell cycle;regulation of signal transduction by p53 class mediator;SH3/SH2 adaptor activity;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;NF-kappaB binding;intrinsic apoptotic signaling pathway by p53 class mediator;positive regulation of execution phase of apoptosis;p53 binding;positive regulation of neuron death	3D-structure;ANK repeat;Alternative splicing;Apoptosis;Cell cycle;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;SH3 domain;SH3-binding	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-109581;R-HSA-5357801;R-HSA-5633007;R-HSA-5633008;R-HSA-6803211;R-HSA-109606;R-HSA-114452;R-HSA-139915;R-HSA-6803204;R-HSA-6803205;R-HSA-6804759	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptosis;Programmed Cell Death;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Death Receptors and Ligands;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Regulation of TP53 Activity through Association with Co-factors
COQ9	negative	MSN	ENSG00000147065	COQ9	1	COQ9	1	0.00970223179625307	WBGene00001333			Combined immunodeficiency due to Moesin deficiency;IMMUNODEFICIENCY 50	GO:0005856;GO:0008092;GO:0045177;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0003779;GO:0005886;GO:0005615;GO:0042995;GO:0005515;GO:0007010;GO:0048471;GO:0005925;GO:0030175;GO:0070062;GO:0019901;GO:0010628;GO:0071944;GO:0072562;GO:0016032;GO:0071437;GO:0005902;GO:0072678;GO:0045198;GO:0016324;GO:0008360;GO:0005102;GO:0035722;GO:0005200;GO:0031982;GO:0061028;GO:0031528;GO:0008361;GO:0022612;GO:0003725;GO:0042098;GO:0031143;GO:0071394;GO:2000401;GO:0019899;GO:1902966;GO:0050839;GO:0007159;GO:0022614;GO:0050900;GO:0009986;GO:0001771;GO:1902115;GO:1903364;GO:2000643;GO:0070489;GO:0071803;GO:0001931;GO:0016323	cytoskeleton;cytoskeletal protein binding;actin binding;apical part of cell;nucleus;cytoplasm;membrane;cytosol;plasma membrane;focal adhesion;extracellular space;cell projection;protein binding;cytoskeleton organization;perinuclear region of cytoplasm;filopodium;extracellular exosome;protein kinase binding;positive regulation of gene expression;cell periphery;blood microparticle;viral process;invadopodium;microvillus;T cell migration;establishment of epithelial cell apical/basal polarity;apical plasma membrane;regulation of cell shape;signaling receptor binding;interleukin-12-mediated signaling pathway;structural constituent of cytoskeleton;vesicle;establishment of endothelial barrier;microvillus membrane;regulation of cell size;gland morphogenesis;double-stranded RNA binding;T cell proliferation;pseudopodium;cellular response to testosterone stimulus;regulation of lymphocyte migration;enzyme binding;positive regulation of protein localization to early endosome;cell adhesion molecule binding;leukocyte cell-cell adhesion;membrane to membrane docking;leukocyte migration;cell surface;immunological synapse formation;regulation of organelle assembly;positive regulation of cellular protein catabolic process;positive regulation of early endosome to late endosome transport;T cell aggregation;positive regulation of podosome assembly;uropod;basolateral plasma membrane	3D-structure;Acetylation;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Host-virus interaction;Membrane;Phosphoprotein;Reference proteome;S-nitrosylation	R-HSA-168256;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-1280215;R-HSA-449147;R-HSA-447115;R-HSA-8950505;R-HSA-9020591	Immune System;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
COQ9	negative	TPM4	ENSG00000167460	COQ9	1	COQ9	1	0.00970223179625307	WBGene00002978	WBGene00002978(1)		Autosomal dominant macrothrombocytopenia;Inflammatory myofibroblastic tumor	GO:0005737;GO:0016020;GO:0046872;GO:0003779;GO:0042803;GO:0005856;GO:0005515;GO:0005509;GO:0005925;GO:0051015;GO:0005829;GO:0070062;GO:0005884;GO:0042802;GO:0007015;GO:0046982;GO:0001725;GO:0006936;GO:0008307;GO:0030049;GO:0001649;GO:0005862	cytoplasm;membrane;metal ion binding;actin binding;cytoskeleton;focal adhesion;protein homodimerization activity;protein binding;identical protein binding;calcium ion binding;actin filament binding;cytosol;extracellular exosome;actin filament;actin filament organization;protein heterodimerization activity;stress fiber;muscle contraction;structural constituent of muscle;muscle filament sliding;osteoblast differentiation;muscle thin filament tropomyosin	Acetylation;Actin-binding;Alternative splicing;Calcium;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;Metal-binding;Muscle protein;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-397014;R-HSA-445355;R-HSA-390522	Muscle contraction;Smooth Muscle Contraction;Striated Muscle Contraction
COQ9	negative	TBK1	ENSG00000183735	COQ9	1	COQ9	1	0.00970223179625307	WBGene00020324			Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease;Herpes simplex virus encephalitis;ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 8;FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4	GO:0004672;GO:0005524;GO:0006468;GO:0045944;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0005654;GO:0005515;GO:0016235;GO:0006954;GO:0002376;GO:0045087;GO:0051607;GO:0005829;GO:0010008;GO:0009615;GO:0016032;GO:0043123;GO:0018105;GO:0033138;GO:0032727;GO:0032728;GO:0035666;GO:0019903;GO:0018107;GO:0032481;GO:0007249;GO:0032480;GO:1901214;GO:0051219;GO:0071345;GO:0032479;GO:0032606;GO:0016239;GO:0003676;GO:0042802;GO:0002218;GO:0010468;GO:0010629;GO:0031323;GO:0044565;GO:0045359;GO:0050830;GO:0060340;GO:1904417	protein kinase activity;ATP binding;protein phosphorylation;positive regulation of transcription by RNA polymerase II;cytoplasm;intracellular membrane-bounded organelle;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;protein binding;inflammatory response;immune system process;innate immune response;defense response to virus;cytosol;endosome membrane;response to virus;viral process;positive regulation of I-kappaB kinase/NF-kappaB signaling;peptidyl-serine phosphorylation;positive regulation of peptidyl-serine phosphorylation;positive regulation of interferon-alpha production;positive regulation of interferon-beta production;TRIF-dependent toll-like receptor signaling pathway;protein phosphatase binding;peptidyl-threonine phosphorylation;positive regulation of type I interferon production;I-kappaB kinase/NF-kappaB signaling;negative regulation of type I interferon production;regulation of neuron death;phosphoprotein binding;cellular response to cytokine stimulus;regulation of type I interferon production;type I interferon production;positive regulation of macroautophagy;nucleic acid binding;identical protein binding;activation of innate immune response;regulation of gene expression;negative regulation of gene expression;regulation of cellular metabolic process;dendritic cell proliferation;positive regulation of interferon-beta biosynthetic process;defense response to Gram-positive bacterium;positive regulation of type I interferon-mediated signaling pathway;positive regulation of xenophagy	3D-structure;ATP-binding;Amyotrophic lateral sclerosis;Antiviral defense;Coiled coil;Cytoplasm;Disease mutation;Glaucoma;Host-virus interaction;Immunity;Innate immunity;Isopeptide bond;Kinase;Neurodegeneration;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-166016;R-HSA-166166;R-HSA-168898;R-HSA-936964;R-HSA-937061;R-HSA-168164;R-HSA-1834949;R-HSA-1606322;R-HSA-168928;R-HSA-936440;R-HSA-9013973;R-HSA-918233;R-HSA-933541;R-HSA-9008059;R-HSA-3134975;R-HSA-1834941;R-HSA-3270619;R-HSA-3249367;R-HSA-1606341	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll-like Receptor Cascades;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling ;Toll Like Receptor 3 (TLR3) Cascade;Cytosolic sensors of pathogen-associated DNA ;ZBP1(DAI) mediated induction of type I IFNs;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling;TICAM1-dependent activation of IRF3/IRF7;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;Interleukin-37 signaling;Regulation of innate immune responses to cytosolic DNA;STING mediated induction of host immune responses;IRF3-mediated induction of type I IFN;STAT6-mediated induction of chemokines;IRF3 mediated activation of type 1 IFN
COQ9	negative	SRGAP2	ENSG00000266028	COQ9	1	COQ9	1	0.00970223179625307	WBGene00006406	WBGene00006406(1)			GO:0007165;GO:0043547;GO:0005096;GO:0005515;GO:0005829;GO:0005654;GO:0005634;GO:0005737;GO:0016020;GO:0042803;GO:0005886;GO:0042995;GO:0030054;GO:0031410;GO:0045202;GO:0045211;GO:0042802;GO:0007399;GO:0048812;GO:0030027;GO:0051056;GO:0014069;GO:0043197;GO:0046847;GO:0048365;GO:0030336;GO:0045335;GO:0003363;GO:0021816;GO:0034446;GO:0051014;GO:0060996;GO:2001223;GO:0044327	protein binding;signal transduction;positive regulation of GTPase activity;GTPase activator activity;nucleoplasm;cytosol;nucleus;cytoplasm;membrane;protein homodimerization activity;plasma membrane;cell projection;cell junction;cytoplasmic vesicle;synapse;postsynaptic membrane;identical protein binding;nervous system development;neuron projection morphogenesis;lamellipodium;regulation of small GTPase mediated signal transduction;postsynaptic density;dendritic spine;filopodium assembly;Rac GTPase binding;negative regulation of cell migration;phagocytic vesicle;lamellipodium assembly involved in ameboidal cell migration;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration;substrate adhesion-dependent cell spreading;actin filament severing;dendritic spine development;negative regulation of neuron migration;dendritic spine head	3D-structure;Cell junction;Cell membrane;Cell projection;Chromosomal rearrangement;Coiled coil;Cytoplasm;Cytoplasmic vesicle;GTPase activation;Membrane;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Reference proteome;SH3 domain;Synapse	R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-376176;R-HSA-195258;R-HSA-5663220;R-HSA-428543	Developmental Biology;Axon guidance;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by ROBO receptors;RHO GTPase Effectors;RHO GTPases Activate Formins;Inactivation of CDC42 and RAC1
